Brief: Telesis Bio Q3 EPS USD -0.37
13/11/2023 21:23
Nov 13 (Reuters) - Telesis Bio Q3 EPS USD -0.37. * Q3 net income USD -10.6 million * Q3 operating expenses USD 13.1 million * Q3 revenue USD 5.6 million * Q3 gross margin 53.9%
Recent news on Telesis Bio
See all newsBrief: Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis
Brief: Telesis Bio Plans To Delist Its Securities From The Nasdaq Stock Market
Brief: Telesis Bio Says Co Entered Share Purchase Agreement With Yuan Yang To Sell All Of Outstanding Capital Stock Of Eton Bio
Telesis Bio Inc reports results for the quarter ended in June - Earnings Summary
Telesis Bio Inc expected to post a loss of $4.03 a share - Earnings Preview